On February 23, 2015 a Pennsylvania jury found Risperdal drug maker Janssen Pharmaceuticals failed to properly warn of the potential for Risperdal to cause gynecomastia, a condition in which males grow enlarged breasts. As a boy, Austin
Pledger, took Risperdal to assist with behavioral symptoms related to autism and later developed size 46DD breasts from taking the drug. The condition was irreversible. The jury awarded Pledger $2.5 million.